Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

VIMRxyn to undergo phase I in glioma patients

Aug. 23, 1996

NeXstar describes ELONA and significance for VEGF inhibitor development

Aug. 23, 1996

Shionogi reports ras transformation inhibitor

Aug. 23, 1996

Farnesyl transferase inhibitors from Pierre Fabre

Aug. 23, 1996

Study indicates ISIS-3521/CGP-64128A inhibits tumor growth

Aug. 23, 1996

IDEC-Y2B8/IDEC-C2B8 combination undergoes phase I/II

Aug. 23, 1996

Fareston launched in the U.K.

Aug. 23, 1996

Phase I pharmacokinetic study of asulacrine initiated

Aug. 23, 1996

Japanese investigators describe antileukemia activity of drupangtonine

Aug. 23, 1996

Taiho discloses antitumor nucleoside drugs

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 19, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...